OptimizeRx
OPRX
$8.13
Share price
-0.37%
Change (1 day)
-26.36%
Change (1 year)
Categories
P/S ratio for OptimizeRx (OPRX)
P/S ratio as of April 2025 (TTM): 1.61
According to OptimizeRx's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.27. At the end of 2024 the company had a P/S ratio of 1.02.
P/S ratio history for OptimizeRx from 2009 to 2024
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2024 | 1.02 | -71.98% |
| 2023 | 3.63 | -21.29% |
| 2022 | 4.61 | -74.37% |
| 2021 | 18.0 | 65.66% |
| 2020 | 10.9 | 78.84% |
| 2019 | 6.08 | -2.21% |
| 2018 | 6.21 | 63.99% |
| 2017 | 3.79 | 22.23% |
| 2016 | 3.10 | -36.79% |
| 2015 | 4.91 | 21.34% |
| 2014 | 4.04 | -20.21% |
| 2013 | 5.07 | -31.2% |
| 2012 | 7.36 | -35.2% |
| 2011 | 11.4 | -92.76% |
| 2010 | 157 | -82.51% |
| 2009 | 898 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 | 1.01 | -37.33% | 🇺🇸 USA |
 | 9.16 | 467.85% | 🇺🇸 USA |
 | 0.2162 | -86.60% | 🇺🇸 USA |
 | 2.01 | 24.62% | 🇺🇸 USA |